ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Instrument Makers Looked To Diagnostics

by Marc S. Reisch
December 24, 2012 | APPEARED IN VOLUME 90, ISSUE 52

[+]Enlarge
Credit: Thermo Fisher Scientific
Thermo Fisher increased its involvement in diagnostics in 2012. Here a technician reviews Thermo microarrays for evidence of patients’ allergies.
09052-cover3ThermoFisherreadercxd.jpg
Credit: Thermo Fisher Scientific
Thermo Fisher increased its involvement in diagnostics in 2012. Here a technician reviews Thermo microarrays for evidence of patients’ allergies.

Scientific instrument makers started the year off with low expectations. At the Pittsburgh Conference on Analytical Chemistry & Applied Spectroscopy in March, executives said world economic uncertainty could restrain instrument sales in 2012 ­following an improvement in 2011.

However, they continued to enlarge their involvement in the market for medical diagnostics. Instrument makers, which for years had enabled research on new drugs, increasingly saw a role for themselves in making diagnostics used by physicians to help choose those drugs at the point of care.

In May, Agilent Technologies agreed to acquire Dako, a Danish cancer diagnostics company, for $2.2 billion. In July, Thermo Fisher Scientific agreed to buy the transplant diagnostics firm One Lambda for $925 million. The same month Life Technologies acquired Navigenics, a personalized genetics test firm, for an undisclosed amount. In September, Danaher signed an agreement to acquire Iris International, a maker of automated urinalysis diagnostic systems and related consumables, for $338 million.

Instrument users encountered some difficulties during the year for which their suppliers did not have a quick and easy answer. Those who use liquid helium to cool nuclear magnetic resonance imaging magnets or to prepare samples for analysis were having trouble buying the inert element. The situation stayed dire for some users, and helium suppliers said the situation would get worse before it gets better.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment